An Optos scan takes only seconds for each eye which can significantly speed up each visit, freeing up time for post-imaging discussions. By spending quality time with patients and sharing their unique UWF images, the opportunity for customer satisfaction increases and, in turn, the likelihood they will positively share their experiences with family or friends increases as well. Explaining to patients that the results of the baseline scan can be used for year-over-year comparisons and can also be shared with other providers, should a specialist be warranted or if a new provider is selected in the future, boasts another benefit to the electronic record created with an optomap exam.  

The workflow of any practice can be greatly impacted by the resources made available to clinical practitioners working in eye care settings. A rise in patient waiting times often leads to delays in the diagnoses and treatment of diseases and disorders. But if a practice flow is fluid, and with the utilisation of advanced retinal imaging technology that provides enhanced eye care, more health issues can be caught earlier, saving sight and lives.

optomap® captures high-resolution 200° ultra-widefield (UWF™) retinal images, that help detect, diagnose, and treat retinal disorders and diseases such as glaucoma, diabetes, and cancer, in a single capture.  Using an Optos retinal imaging device, the process is painless, takes only seconds to capture an image, reduces patient wait times, improving patient satisfaction.

Prevent Blindness has declared February AMD Awareness month[1].  Age-related macular degeneration(AMD) is the most common cause of severe loss of eyesight among people 50 and older.

AMD affects the central vision, and with it, the ability to see fine details. With AMD, the macula, a part of the retina in damaged. In its early stages, AMD may have no signs or symptoms, so people may not suspect they have it. In advanced stages, people lose their ability to drive, to see faces, and to read smaller print. AMD by itself does not lead to complete blindness, with no ability to see. However, the loss of central vision in AMD can severely interfere with simple everyday activities

.

Make a wish come true with an Optos purchase. Get Optos off your wish list and into your practice.  We understand that an upfront purchase of an Optos device can feel daunting. But adopting advanced retinal imaging technology can start driving revenue in your practice the moment you invest.

optomap enables eyecare professionals to discover, diagnose, document, and treat ocular pathology . Recent studies suggest that UWF imaging may be suitable for diagnosing glaucoma in situations where slit-lamp biomicroscopy or digital color stereoscopy are not available. Another study also confirms that optomap has almost perfect agreement with color digital stereoscopy when assessed by a glaucoma specialist

Expanding on a past topic for OptosAdvance users looking to better utilize their software, we have now provided a new set of tips and tricks to using your mouse within OptosAdvance to get the most efficient image review process. Scroll to the bottom to download the full PDF. 

Investment in the latest retinal imaging technology is a commitment to grow your practice years into the future. Improve your bottom line and customer retention with innovations in eye care that help patients receive the best care possible. Features such as multimodality are helping to save sight with the early detection of potential disease and disorders. Advancements in eye care also reduce NHS waiting times and protect the lives of patients.

Regular comprehensive eye exams are crucial for detecting and managing diabetic eye issues. Diabetic retinopathy, for example, can often be treated more effectively if caught early. If you have diabetes, it's essential to work closely with your healthcare team to control your blood sugar levels, manage your overall health, and have regular eye exams to catch any potential eye problems early.

At Optos, our technology facilitates the early detection, management and effective treatment of disorders and diseases evidenced in the retina such as diabetic retinopathy. More than 2,500 published and ongoing clinical trials as well as thousands of case studies and testimonials show the long-term value of optomap imaging in diagnosis, treatment planning, and patient engagement in diabetic screening and diabetic eye exams. For more information about Optos and optomap, please visit www.optos.com

Each year, November 14th is recognized as World Diabetes Day and this year’s theme is “Education to Protect Tomorrow”. Understanding the condition is the first step towards managing and preventing it. One in 10 adults around the world currently live with diabetes, an estimated 537 million people. Almost half do not know they have it.